...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Additional Exempt Distributions
2
Sep 17, 2023 04:45PM

Toinv read note 5 of the latest ZCC financials and see what you make of it.

Promissory notes primarily are made by the chief executive and a friend of the chief executive, payable on demand and are secured by a security interest in all of the Company’s assets. Up to July 31, 2023, Promissory notes total $4.39 Mil US and counting.

 

Koo

Share
New Message
Please login to post a reply